ArticleOrphanet journal of rare diseases2025
RNA-binding proteins regulate immune-related alternative splicing in inherited salt-losing tubulopathies.
Article in Orphanet journal of rare diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundInherited salt-losing tubulopathies (SLT) are rare disorders caused by gene mutations that disrupt renal tubular ion transport. However, the molecular mechanisms underlying SLT pathogenesis remain unclear. This study aims to elucidate the functional genes and potential regulatory mechanisms associated with SLT.
methodsWe established a study cohort comprising inherited SLT patients, age-matched patients with acquired hypokalemia, and healthy volunteers. Clinical characteristics were compared among the groups. RNA sequencing (RNA-seq) was performed to obtain transcriptomic profiles, followed by analysis of gene expression patterns and alternative splicing events (ASEs). Key findings were validated using RT-qPCR.
resultsSLT patients exhibited a higher prevalence of recurrent viral infections (65%, P = 0.004) and autoimmune thyroid disorders (30%, P = 0.022) compared to healthy controls. RNA-seq analysis identified 2,611 differentially expressed genes (DEGs) in SLT patients, including 1,236 upregulated and 1,375 downregulated genes. These DEGs were primarily enriched in innate immune responses and adaptive immunity pathways. Additionally, significant alterations in gene expression related to viral defense and stress responses were observed. Notably, we identified several RNA-binding proteins (RBPs) that may contribute to SLT pathogenesis by regulating ASEs of immune-related genes.
conclusionOur findings highlight the critical role of RBPs in SLT pathogenesis and provide novel insights into the immune profiles and gene expression dynamics in SLT. This study lays the foundation for future research into targeted therapies and personalized treatment strategies for SLT management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.